DYNAVAX TECHNOLOGIES CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.54 USD | -1.16% |
|
+3.58% | -17.24% |
| 01/04 | Dynavax Technologies Corporation Announces Chief Financial Officer Changes | CI |
| 23/02 | Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue | MT |
Chart calendar Dynavax Technologies Corporation
bd7502ac5396a8451e0.UpEkWDuauWiq0UPSwsr99mwJU_va7XCa2tkYvUrv5as.AvhJHVT_0gn9iAjkrryZvVpeNJG1nAGivexChRjWqvg02HU5D8vsAJLoFg~6af57484a24de06205d2cd6c990b8a36
Upcoming events on Dynavax Technologies Corporation
Past events on Dynavax Technologies Corporation
| 04/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 23/02/2024 03:00 am | Q4 2023 Earnings Call |
| 23/02/2024 02:31 am | Q4 2023 Earnings Release |
| 12/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 29/11/2023 03:10 am | Evercore ISI HealthCONx Conference |
| 03/11/2023 02:00 am | Q3 2023 Earnings Call |
| 03/11/2023 01:31 am | Q3 2023 Earnings Release |
| 25/10/2023 10:30 pm | H.C. Wainwright NASH Investor Conference |
| 13/09/2023 09:30 pm | H.C. Wainwright Global Investment Conference |
| 04/08/2023 02:00 am | Q2 2023 Earnings Call |
| 04/08/2023 01:35 am | Q2 2023 Earnings Release |
| 12/06/2023 11:50 pm | Goldman Sachs Global Healthcare Conference |
| 06/06/2023 07:50 pm | William Blair Growth Stock Conference |
| 06/06/2023 | National Foundation for Infectious Diseases online Conference |
| 26/05/2023 09:30 pm | Annual General Meeting |
| 15/05/2023 10:30 pm | JMP Securities Life Sciences Conference |
| 03/05/2023 02:00 am | Q1 2023 Earnings Call |
| 03/05/2023 01:35 am | Q1 2023 Earnings Release |
| 09/03/2023 12:40 am | Cowen Health Care Conference |
| 24/02/2023 03:00 am | FY 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 35,2 36,3 -3.05% | 46,6 40,1 16.19% | 439 449 -2.22% | 723 718 0.68% | 232 230 0.91% | 288 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 141 103 37.94% | 290 285 1.83% | -29,8 -28,3 -5.28% | 24,5 |
|
EBIT Million USD | Released Forecast Spread | -135 -133 -1.57% | -68,4 -78,6 13.02% | 134 122 9.94% | 284 286 -0.76% | -37,0 -38,8 4.5% | -3,53 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -153 -144 -6.03% | -75,2 -88,4 14.92% | 77,5 41,7 85.76% | 294 293 0.3% | -4,37 -6,82 35.97% | 35,1 |
|
Net income Million USD | Released Forecast Spread | -156 -144 -8.3% | -75,2 -88,4 14.92% | 76,7 52,3 46.57% | 293 296 -1.1% | -6,39 -9,27 31.05% | 27,4 |
|
EPS USD | Released Forecast Spread | -2,16 -2,04 -5.88% | -0,78 -0,88 10.86% | 0,57 0,45 26.67% | 1,97 1,91 3.14% | -0,05 -0,13 62.26% | 0,23 |
| Announcement Date | 11/03/20 | 25/02/21 | 28/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 195 209 -6.61% | 114 154 -26.12% | 256 151 69.85% | 168 159 5.22% | 184 180 2.72% | 46,9 38,6 21.6% | 60,2 48,4 24.53% | 69,5 61,4 13.14% | 55,6 52,7 5.44% | 55,0 | 78,4 | 87,8 | 65,8 |
|
EBIT Million USD | Released Forecast Spread | 80,7 71,1 13.51% | 30,8 52,4 -41.28% | 128 43,3 196.04% | 61,4 45,3 35.67% | 63,1 65,3 -3.33% | -30,2 -19,4 -55.91% | -3,41 -15,7 78.34% | 5,12 -6,11 183.71% | -8,49 -10,2 17.11% | -12,3 | 5,67 | 11,7 | -8,57 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 101 82,9 21.36% | 32,9 35,6 -7.78% | 129 32,9 293.62% | 64,1 49,1 30.5% | 68,0 71,1 -4.41% | -23,7 -14,9 -58.71% | 4,21 -10,2 141.25% | 14,1 1,34 952.79% | 1,00 -2,35 142.39% | -4,26 | 14,6 | 19,6 | -1,00 |
|
Net income Million USD | Released Forecast Spread | 99,8 81,5 22.38% | 32,9 35,6 -7.64% | 129 32,9 291.74% | 63,8 49,1 30.08% | 67,7 71,0 -4.6% | -24,3 -14,9 -62.84% | 3,43 -10,2 133.64% | 14,3 1,18 1114.36% | 0,22 -2,66 108.23% | -4,26 | 14,6 | 18,1 | -1,03 |
|
EPS USD | Released Forecast Spread | 0,55 0,64 -14.06% | 0,22 0,24 -8.33% | 0,87 0,22 295.45% | 0,43 0,33 31.3% | 0,45 0,45 -0.55% | -0,19 -0,13 -43.4% | 0,03 -0,09 132.43% | 0,10 -0,02 766.67% | 0,00 -0,02 - | -0,03 | 0,08 | 0,11 | -0,01 |
| Announcement Date | 28/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 02/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | - | - | - | - |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | BIONTECH SE: Q1 2024 Earnings Release |
| 06/05/2024 04:30 pm | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:31 am | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| 07/05/2024 | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Dynavax Technologies Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DVAX Stock
- Calendar Dynavax Technologies Corporation
